Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: ELOX) | Delayed: 13.74 -1.44 (9.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.18 | 52 Week High | $ | |||
| Open | $15.02 | 52 Week Low | $ | |||
| Day High | $15.29 | P/E | N/A | |||
| Day Low | $13.21 | EPS | $ | |||
| Volume | 31,308 | |||||



